These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 2402229)

  • 1. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
    Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
    Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
    Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
    Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
    Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R
    Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Blood; 1991 Mar; 77(6):1313-9. PubMed ID: 2001454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
    Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory peptides in hematopoiesis.
    Guigon M; Bonnet D
    Exp Hematol; 1995 Jun; 23(6):477-81. PubMed ID: 7768302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomolecules suppressing myelopoiesis].
    Gebran S; Romano E; Soyano A
    Acta Cient Venez; 1992; 43(5):255-68. PubMed ID: 1343739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemoprotection against cytostatic drugs by stem cell inhibition.
    Moser MH; Paukovits WR
    Trends Pharmacol Sci; 1991 Aug; 12(8):304-10. PubMed ID: 1949198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity.
    Paukovits WR; Hergl A; Schulte-Hermann R
    Mol Pharmacol; 1990 Sep; 38(3):401-9. PubMed ID: 2402229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Cancer Treat Rev; 1990 Sep; 17(2-3):347-54. PubMed ID: 2272050
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.